Skin Therapy Letter, Index to Volume 2 (2 of 2)

Skin Therapy Letter

	Back to Skin Therapy Letter Home Page	Link to DermWebat UBC

	Comments or suggestions?	Subscription Information

Index • Volume 2 • Part 2 of 2

Articles are indexed by drug names, trade-names (marked ®), and disease terms. Bold entries refer to major references.

Return to Part 1 of 2...

Drug name

Issue: Page

LacHydrin®

4: 5

Lacticare®

4: 5

Lamisil

4: 6

Lamivudine (3TC)

3: 4

Laser device

2: 6

Levaquin®

3: 6

Levofloxacin

3: 6

Lice

2: 6

6: 3

Lidocaine & epinephrine

1: 6

Lidocaine gel

4: 4

4: 5

Lindane shampoo

6: 4

Lipids

4: 2

Loratidine

3: 6

Lupus erythemat. - drug induced

1: 4

Lyme disease

3: 6

Mafenide acetate

6: 2

Malathion shampoo

6: 4

Mectizan®

2: 6

Mentax® cream

2: 6

3: 6

Mepitel®

6: 5

Methotrexate

2: 5

Microsporum canis

6: 3

Minocycline

1: 4

Minoxidil

2: 3

Monolaurin

4: 2

Nelfinavir

5: 6

6: 6

Neutrogena Hand Cream®

4: 5

Nix®

2: 6

6: 4

Nizoral shampoo®

6: 3

Norgestimate / ethinyl estradiol

3: 1

3: 6

Norvir®

6: 6

Nystatin

6: 2

Onchocerciasis

2: 6

Onychomycosis

2: 6

Oral contraceptives

3: 1

Ortho Tricyclen®

3: 1

3: 6

P & S liquid (Phenol/Saline)

2: 5

Penciclovir cream

2: 6

6: 1

PEP (Post-exposure prophylaxis)

3: 3

Permethrin

2: 6

Permethrin shampoos

6: 5

Petrolatum

4: 5

Pityrosporum ovale

6: 3

Plaque psoriasis

4: 1

5: 6

6: 6

Podofilox gel

5: 6

Poison ivy, oak & sumac

1: 3

Polymyxin B sulfate

6: 2

Post herpetic neuralgia

4: 3

5: 2

Povidone iodine solution

6: 2

Prednisolone, prednisone

4: 4

Procepia®

2: 4

Progestins

3: 1

Proprionibacteria

2: 1

Protease inhibitors

5: 6

6: 6

Psoriasis

2: 2	2: 5	2: 6
3: 6

Pulsed Er Yag laser system

5: 6

PUVA

2: 5

Pyrethrum shampoos

6: 4

Quaternium 18 bentonite

1: 3

1: 6

Retin A Micro®

4: 6

5: 6

Retrovir®

3: 4

Ringworm

6: 3

Ritonavir®

6: 6

Rogaine ® (and Regaine ®)

2: 3

Rosacea

3: 6

Salacylic acid in oil

2: 5

Saquinavir

6: 6

Sandimmune®

6: 6

Scabies

2: 6

Scalp camouflage

2: 4

Scalp psoriasis

2: 2

2: 5

6: 3

Scarlet Red Dressing

6: 2

Seborrheic dermatitis

3: 6

6: 3

Selecting a sunscreen

5: 3

Selenium sulfide

6: 4

Selsun Blue®

6: 3

Shampoos

2: 2

Shampoos - Medicated

6: 3

Sharplan silktouch laser®

2: 6

Silastic®

1: 5

Silicone gel sheeting

1: 5

Skin Cap

6: 3

Sodium hypochlorite

6: 2

Sodium sulphacetamide lotion

3: 6

Soriatane®

2: 6

6: 6

Sorivudine

1: 6

Spironolactone

2: 3

Sporanox®

2: 6

4: 6

Staphylococci

2: 1

Strongyloidiasis

2: 6

Sulfacet R®

3: 6

Sulfonamides

1: 4

Sulphur shampoo

6: 3

Sunscreens

5: 3

Sex hormone binding globulin

3: 1

3 TC

3: 4

Tar

2: 5

Tazarotene ( Tazorac® )

3: 6	4: 1	4: 6
6: 6

Tegapore

6: 5

TENS

5: 5

Terbinafine HCl cream

4: 6

Tetracycline

1: 4

3 TC

3: 4

Tincoban

6: 2

Tinea capitis

6: 4

Tinea corpora, cruris

3: 6

4: 6

Tinea pedis

2: 6

Tinea versicolor

6: 6

Tretinoin cream

4: 6

Tretinoin gel microsphere

4: 6

Triamcinolone

4: 4

Trichophytum tonsurans

6: 4

Tricyclic antidepressants

4: 4

5: 2

Uroshiol

1: 3

Urticaria

3: 6

UVA, UVB

5: 3

Vaccine - herpes simplex

3: 5

5: 5

- herpes zoster

5: 5

Valaciclovir ( Valtrex® )

1: 6	2: 6	3: 5
4: 3	5: 2	5: 6

Varicella zoster

1: 1

5: 5

Vaseline Intensive Care Lotion®

4: 5

Vectavir®

6: 1

Venous leg ulcers

5: 1

6: 2

Viracept

5: 6

6: 6

Viral shedding

1: 1

3: 5

6: 1

Warts

4: 6

Xerosis

4: 2

Zidovudine (ZDV)

3: 4

Zinc pyrithione

6: 3

Zinc sulphate

6: 2

Zostrix®

5: 5

Zovirax®

3: 5

4: 3

5: 2

EDITOR: Stuart Maddin Associate Editor: David I. McLean INTERNET EDITOR: Harvey Lui PRINCIPAL MEDICAL WRITER: Susan Kingsley Manuscript Editor: Rodger Hall Editorial Advisory Board: Kenneth A. Arndt, Beth Israel Hospital & Harvard Medical School, Boston; Wilma Fowler Bergfeld, Cleveland Clinic, Cleveland; Jan D. Bos, University of Amsterdam, Amsterdam; Enno Christophers, Universitäts-Hautklinik, Kiel; Hugo Degreef, Catholic University, Leuven; Richard L. Dobson, Medical University of South Carolina, Charleston; Boni E. Elewski, Case Western Reserve University, Cleveland; Barbara A. Gilchrest, Boston University School of Medicine, Boston; W. Andrew D. Griffiths, St. Johns Institute of Dermatology, London; Vincent C.Y. Ho, University of British Columbia, Vancouver; James J. Leyden, University of Pennsylvania, Philadelphia; Howard I. Maibach, University of California Hospital, San Francisco; Larry E. Millikan, Tulane University Medical Center, Louisiana; Takeji Nishikawa, Keio University School of Medicine, Tokyo; Constantin E. Orfanos, Freie Universitäts Berlin, Universitätsklinikum Benjamin Franklin, Berlin; Stephen L. Sacks, Viridae Clinic Sciences, Vancouver; Alan R. Shalita, SUNY Health Sciences Center, Brooklyn; Stephen K. Tyring, University of Texas Medical Branch, Galveston; John Voorhees, University of Michigan, Ann Arbor; Klaus Wolff, University of Vienna, Vienna

Skin Therapy Letter®. (ISSN 1201-5989) Copyright 1997 by International Skin Therapy Newsletter Inc. All rights reserved. Reproduction in whole or in part by any process in whole or in part is strictly forbidden without prior consent of the publisher in writing.
Published six times yearly by International Skin Therapy Newsletter Inc., 835 West Tenth Avenue, Vancouver, British Columbia, Canada V5Z 4E8. Tel: (604) 874-6112. Fax: (604) 873-9919. Annual subscription: Canadian $85 individual; $155 institutional (GST included). US $60 individual; $110 institutional. Outside North America: US$80 individual; $130 institutional. Quotes on multiple subscriptions and student rates supplied upon request.

Skin Therapy Letter •Editor: Dr. Stuart Maddin •Index to Volume 2

Return to Top